Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue SUPPL.1, 2012, Pages 77-82

  Jusakul, Apinya ^a,b   Khuntikeo, Narong ^a   Haigh, W Geoffrey ^b   Kuver, Rahul ^b   Ioannou, George N ^b   Loilome, Watcharin ^a   Namwat, Nisana ^a   Bhudhisawasdi, Vajarabhongsa ^a   Pugkhem, Ake ^a   Pairojkul, Chawalit ^a   Yongvanit, Puangrat ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Bile acids; Cholangiocarcinoma; Hepatocellular carcinoma

Indexed keywords

BILE ACID;

BILE DUCT CARCINOMA; BILE DUCT TUMOR; BLOOD; HUMAN; INTRAHEPATIC BILE DUCT; LIVER CELL CARCINOMA; LIVER TUMOR;

BILE ACIDS AND SALTS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HUMANS; LIVER NEOPLASMS;

EID: 84874064912     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.KKSuppl.77     Document Type: Article

References (33)

1. Alpini G, Baiocchi L, Glaser S, et al (2002a). Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha. Hepatology, 35, 1041-52.
2. Alpini G, Glaser S, Alvaro D, et al (2002b). Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats. Gastroenterology, 123, 1226-37.
3. Alpini G, Glaser SS, Ueno Y, et al (1999). Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. Gastroenterology, 116, 179-86.
4. Alpini G, Ueno Y, Glaser SS, et al (2001). Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes. Hepatology, 34, 868-76.
5. Bayerdorffer E, Mannes GA, Ochsenkuhn T, et al (1995). Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut, 36, 268-73.
6. Bernstein H, Bernstein C, Payne CM, Dvorak K (2009). Bile acids as endogenous etiologic agents in gastrointestinal cancer. World J Gastroenterol, 15, 3329-40.
7. Boonyanugomol W, Chomvarin C, Sripa B, et al (2012). Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB (Oxford), 14, 177-84.
8. Booth LA, Gilmore IT, Bilton RF (1997). Secondary bile acid induced DNA damage in HT29 cells: are free radicals involved? Free Radic Res, 26, 135-44.
9. Cameron RG, Imaida K, Tsuda H, Ito N (1982). Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine. Cancer Res, 42, 2426-8.
10. Changbumrung S, Tungtrongchitr R, Migasena P, Chamroenngan S (1990). Serum unconjugated primary and secondary bile acids in patients with cholangiocarcinoma and hepatocellular carcinoma. J Med Assoc Thai, 73, 81-90.
11. Chiang JY (2009). Bile acids: regulation of synthesis. J Lipid Res, 50, 1955-66.
12. Cooper AD, Ockner RK (1974). Studies of hepatic cholesterol synthesis in experimental acute biliary obstruction. Gastroenterology, 66, 586-95.
13. Craven PA, Pfanstiel J, DeRubertis FR (1987). Role of activation of protein kinase C in the stimulation of colonic epithelial proliferation and reactive oxygen formation by bile acids. J Clin Invest, 79, 532-41.
14. Crowley-Weber CL, Payne CM, Gleason-Guzman M, et al (2002). Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis, 23, 2063-80.
15. Dai J, Wang H, Shi Y, et al (2011). Impact of bile acids on the growth of human cholangiocarcinoma via FXR. J Hematol Oncol, 4, 41.
16. Debruyne PR, Bruyneel EA, Karaguni IM, et al (2002). Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene, 21, 6740-50.
17. Funabiki T, Sugiue K, Matsubara T, Amano H, Ochiai M (1991). Bile acids and biliary carcinoma in pancreaticobiliary maljunction. Keio J Med, 40, 118-22.
18. Hong SS, Kim KH, Kim WJ (1973). Effect of bile acids on biliary excretion of cholesterol in rabbits. Yonsei Med J, 14, 109-15.
19. Jansen PL (2007). Endogenous bile acids as carcinogens. J Hepatol, 47, 434-5.
20. Kauer WK, Stein HJ (2002). Role of acid and bile in the genesis of Barrett's esophagus. Chest Surg Clin N Am, 12, 39-45.
21. Kinami Y, Ashida Y, Gotoda H, et al (1993). Promoting effects of bile acid load on the occurrence of cholangiocarcinoma induced by diisopropanolnitrosamine in hamsters. Oncology, 50, 46-51.
22. Kinami Y, Ashida Y, Seto K, Takashima S, Kita I (1990). Influence of incomplete bile duct obstruction on the occurrence of cholangiocarcinoma induced by diisopropanolnitrosamine in hamsters. Oncology, 47, 170-6.
23. Kinugasa T, Uchida K, Kadowaki M, et al (1981). Effect of bile duct ligation on bile acid metabolism in rats. J Lipid Res, 22, 201-7.
24. Kuwahara A, Saito T, Kobayashi M (1989). Bile acids promote carcinogenesis in the remnant stomach of rats. J Cancer Res Clin Oncol, 115, 423-8.
25. Migasena S, Egoramaiphol S, Tungtrongchitr R, Migasena P (1983). Study on serum bile acids in opisthorchiasis in Thailand. J Med Assoc Thai, 66, 464-9.
26. Plaa GL, de Lamirande E, Lewittes M, Yousef IM (1982). Liver cell plasma membrane lipids in manganese-bilirubin-induced intrahepatic cholestasis. Biochem Pharmacol, 31, 3698-701.
27. Puju S, Shuker DE, Bishop WW, et al (1982). Mutagenicity of N-nitroso bile acid conjugates in Salmonella typhimurium and diploid human lymphoblasts. Cancer Res, 42, 2601-4.
28. Reveille RM, Van Stiegmann G, Everson GT (1990). Increased secondary bile acids in a choledochal cyst. Possible role in biliary metaplasia and carcinoma. Gastroenterology, 99, 525-7.
29. Ross RK, Hartnett NM, Bernstein L, Henderson BE (1991). Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen? Br J Cancer, 63, 143-5.
30. Sirica AE (2005). Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology, 41, 5-15.
31. Tucker ON, Dannenberg AJ, Yang EK, Fahey TJ (2004). Bile acids induce cyclooxygenase-2 expression in human pancreatic cancer cell lines. Carcinogenesis, 25, 419-23.
32. Yoon JH, Higuchi H, Werneburg NW, Kaufmann SH, Gores GJ (2002a). Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology, 122, 985-93.
33. Yoon JH, Werneburg NW, Higuchi H, et al (2002b). Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism. Cancer Res, 62, 6500-5.